首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of digestive diseases

缩写:J DIGEST DIS

ISSN:1751-2972

e-ISSN:1751-2980

IF/分区:2.3/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1390
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Junjie Huang,Claire Chenwen Zhong,Zhaojun Li et al. Junjie Huang et al.
Objectives: To identify the risk factors for the survival of colorectal cancer (CRC) patients with type 2 diabetes mellitus (T2DM), compare the predictive performance of models based on different algorithms, and develop a...
Chu Yi Zheng,Yong Jie Tan,Cheng Bei Zhou et al. Chu Yi Zheng et al.
Objectives: Factors such as Helicobacter pylori eradication and the implementation of widespread early cancer screening have significantly influenced clinicopathological features and patient outcomes in gastric cancer (GC...
Ya Long Zhu,Chang Zheng Liu,Yue Li Ya Long Zhu
Ulcerative colitis (UC) is a multifactorial inflammatory bowel disease influenced by genetic susceptibility, environmental triggers, impaired intestinal epithelial barrier function, dysbiosis of gut microbiota, and immune dysregulation. Ubi...
Yi Wei Zhang,Ling Jiao Gong,Fei Liao Yi Wei Zhang
The global prevalence of inflammatory bowel disease (IBD) has been increasing in recent years, paralleling a growing recognition of gut dysbiosis as a pivotal etiological factor. Emerging evidence reveals intricate crosstalk between the ora...
Wei Yue Li,Huan Zhang,Song Bo Li et al. Wei Yue Li et al.
Objectives: Digestive system cancer (DSC) continues to pose a significant global health challenge, and cost-effective biomarkers for its early detection remain scarce. We aimed to evaluate the potential of two biological ...
Ying Lian Xiao,Ya Qi Jia,Li Qun Gu et al. Ying Lian Xiao et al.
Objective: We conducted this systematic review and meta-analysis to summarize the prevalence of celiac disease (CeD) among high-risk populations in China. ...
Neta Sror,Haim Leibovitzh,Ayal Hirsch et al. Neta Sror et al.
Objectives: Upadacitinib (UPA) and vedolizumab (VDZ) have been approved to treat moderate-to-severe ulcerative colitis (UC); however, direct comparative data between these two regimens are lacking. We aimed to compare the...
Eleni Theocharidou,Thomas Gossios Eleni Theocharidou
Dyslipidemia is common in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and, along with other metabolic comorbidities, accounts for an increased cardiovascular risk. Effective treatment of dyslipidemia not o...